Pfizer Inc. (NYSE:PFE) shares, rose in value, with the stock price down by -0.19% to the previous day’s close as strong demand from buyers drove the stock to $26.27.
Actively observing the price movement in the last trading, the stock closed the session at $26.32. The PE ratio was 73.09 over 12-month period. Referring to stock’s 52-week performance, its high was $40.37, and the low was $25.23. On the whole, PFE has fluctuated by -4.23% over the past month.
The company’s Forward Dividend Ratio is 1.65, with its dividend yield at 6.28%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 60.02B, with a low estimate of 12.75B and a high estimate of 16.46B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 14.01B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PFE’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of PFE currently trading nearly -1.20% and -2.91% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.63, while the 7-day volatility ratio is showing 1.58% which for the 30-day chart, stands at 1.61%. Furthermore, Pfizer Inc. (PFE)’s beta value is 0.61, and its average true range (ATR) is 0.46.
A comparison of Pfizer Inc. (PFE) with its peers suggests the former has fared considerably weaker in the market. PFE showed an intraday change of -0.19% in last session, and over the past year, it shrunk by -34.18%%.
Data on historical trading for Pfizer Inc. (NYSE:PFE) indicates that the trading volumes over the past 3 months, they’ve averaged 42.59 million. According to company’s latest data on outstanding shares, there are 5.65 billion shares outstanding.
Nearly 0.04% of Pfizer Inc.’s shares belong to company insiders and institutional investors own 70.10% of the company’s shares. The stock has fallen by -8.75% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PFE stock heading into the next quarter.
